CHEK
🚫 does not pay dividends

Company News

MBody AI and Check-Cap Enter into Definitive Merger Agreement
GlobeNewswire Inc. • Na • September 12, 2025

MBody AI and Check-Cap Ltd. announced a definitive merger agreement to create a combined company focused on embodied AI for the autonomous workforce, with MBody AI shareholders owning 90% of the new entity and Check-Cap shareholders owning 10%.

MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
GlobeNewswire Inc. • Medipharm Labs Corp. • May 23, 2025

MediPharm Labs warns shareholders about the involvement of three director nominees from Apollo Technology Capital Corporation in the troubled events at Check-Cap Ltd., raising concerns about their suitability to take control of the MediPharm board.

Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders
Benzinga • Prnewswire • May 14, 2025

Apollo Technology Capital, a major shareholder of MediPharm Labs, poses critical questions for the company's management to address on their upcoming conference call, citing concerns over MediPharm's poor performance, lack of transparency, and excessive executive compensation.

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga • Avi Kapoor • March 26, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here...

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
Benzinga • Avi Kapoor • March 26, 2024

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Check-Cap Ltd....

Related Companies